Brandon S Aylward1, Joseph R Rausch2, Avani C Modi2. 1. Department of Pediatrics, Emory University School of Medicine, Department of Neurology and Sibley Heart Center Cardiology, Children's Healthcare of Atlanta, and Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center Department of Pediatrics, Emory University School of Medicine, Department of Neurology and Sibley Heart Center Cardiology, Children's Healthcare of Atlanta, and Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center Department of Pediatrics, Emory University School of Medicine, Department of Neurology and Sibley Heart Center Cardiology, Children's Healthcare of Atlanta, and Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center baylwar@emory.edu. 2. Department of Pediatrics, Emory University School of Medicine, Department of Neurology and Sibley Heart Center Cardiology, Children's Healthcare of Atlanta, and Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center.
Abstract
OBJECTIVE: The primary aim of the current study was to use new methods to examine 1-year quality of medication dosing (adherence) and continuation with medication treatment (persistence) rates to antiepileptic drugs (AEDs) in children with newly diagnosed epilepsy. METHODS: Medication-taking behaviors of AEDs were assessed using electronic monitors for 117 children with newly diagnosed epilepsy for the first year after diagnosis. RESULTS: Approximately 15% of participants were categorized as nonpersistent (i.e., failed to take medication for >15 consecutive days) 6 months after AED initiation, which increased to 26.6% of participants at 1 year. The majority of medication dosing events took place within a +/-2-hr interval as recommended. The group with lower socioeconomic status demonstrated more nonpersistence over time. CONCLUSION: Examining adherence and persistence in medication taking behaviors may yield different types of data for clinical and research purposes.
OBJECTIVE: The primary aim of the current study was to use new methods to examine 1-year quality of medication dosing (adherence) and continuation with medication treatment (persistence) rates to antiepileptic drugs (AEDs) in children with newly diagnosed epilepsy. METHODS: Medication-taking behaviors of AEDs were assessed using electronic monitors for 117 children with newly diagnosed epilepsy for the first year after diagnosis. RESULTS: Approximately 15% of participants were categorized as nonpersistent (i.e., failed to take medication for >15 consecutive days) 6 months after AED initiation, which increased to 26.6% of participants at 1 year. The majority of medication dosing events took place within a +/-2-hr interval as recommended. The group with lower socioeconomic status demonstrated more nonpersistence over time. CONCLUSION: Examining adherence and persistence in medication taking behaviors may yield different types of data for clinical and research purposes.
Authors: Bernard Vrijens; Eric Tousset; Richard Rode; Richard Bertz; Steve Mayer; John Urquhart Journal: J Clin Pharmacol Date: 2005-04 Impact factor: 3.126
Authors: Jennifer Rohan; Dennis Drotar; Kelly McNally; Mark Schluchter; Kristin Riekert; Pamela Vavrek; Amy Schmidt; Susan Redline; Carolyn Kercsmar Journal: J Pediatr Psychol Date: 2009-08-26
Authors: Helen Tremlett; Ingrid Van der Mei; Fotini Pittas; Leigh Blizzard; Glenys Paley; Terence Dwyer; Bruce Taylor; Anne-Louise Ponsonby Journal: Pharmacoepidemiol Drug Saf Date: 2008-06 Impact factor: 2.890
Authors: Cyd K Eaton; Michelle N Eakin; Shayna Coburn; Cozumel S Pruette; Tammy M Brady; Barbara A Fivush; Susan Mendley; Shamir Tuchman; Kristin A Riekert Journal: J Pediatr Psychol Date: 2019-01-01
Authors: Konsta Teppo; Jussi Jaakkola; Fausto Biancari; Olli Halminen; Miika Linna; Jari Haukka; Jukka Putaala; Paula Tiili; Ossi Lehtonen; Mikko Niemi; Pirjo Mustonen; Janne Kinnunen; Juha Hartikainen; K E Juhani Airaksinen; Mika Lehto Journal: Pharmacol Res Perspect Date: 2022-06
Authors: Elżbieta Niechciał; Carlo L Acerini; Scott T Chiesa; Tracey Stevens; R Neil Dalton; Denis Daneman; John E Deanfield; Timothy W Jones; Farid H Mahmud; Sally M Marshall; H Andrew W Neil; David B Dunger; M Loredana Marcovecchio Journal: Diabetes Care Date: 2020-02-27 Impact factor: 19.112
Authors: Kira Bona; Yimei Li; Lena E Winestone; Kelly D Getz; Yuan-Shung Huang; Brian T Fisher; Ami V Desai; Troy Richardson; Matt Hall; Arlene Naranjo; Tara O Henderson; Richard Aplenc; Rochelle Bagatell Journal: J Natl Cancer Inst Date: 2021-03-01 Impact factor: 11.816
Authors: Muhammad Arif Asghar; Ahad Abdul Rehman; Muhammad Liaquat Raza; Yousra Shafiq; Muhammad Asif Asghar Journal: BMC Health Serv Res Date: 2021-01-19 Impact factor: 2.655